Novavax, Inc. (NVAX) — Financial statements
Income statement, balance sheet, and cash flow for Novavax, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,123↑64.7% | 682↑22.6% | 556↓65.2% | 1,599↑709.3% | 198 | |
| Cost of Revenue | 71↓64.9% | 203↓41.0% | 344↓61.9% | 903 | 0.00 | |
| Gross Profit | 1,052↑119.5% | 479↑125.5% | 213↓69.5% | 696↑252.4% | 198 | |
| Operating Expenses | ||||||
| R&D Expenses | 337↓13.9% | 391↓47.0% | 738↓40.3% | 1,235↓51.3% | 2,535 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↓100.0% | 489↑63.8% | 298 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 150↓55.4% | 337↓28.1% | 469↓4.0% | 489↑63.8% | 298 | |
| Other Expenses | 2 | 0.00↑100.0% | -427↓11.6% | -383↑59.6% | -949 | |
| Operating Expenses | 489↓32.9% | 728↓6.5% | 779↓41.9% | 1,341↓28.8% | 1,884 | |
| Total Costs & Expenses | 560↓39.8% | 931↓17.1% | 1,123↓50.0% | 2,244↑19.1% | 1,884 | |
| Operating Results | ||||||
| Operating Income | 563↑326.3% | -249↑56.1% | -567↑12.1% | -645↑61.8% | -1,687 | |
| Depreciation & Amortization | 28↓43.1% | 48↑17.6% | 41↑41.9% | 29↑129.5% | 13 | |
| EBITDA | 492↑555.7% | -108↑77.8% | -487↑19.4% | -605↑64.0% | -1,681 | |
| EBIT | 465↑396.9% | -157↑70.4% | -529↑16.6% | -634↑62.6% | -1,693 | |
| Interest & Other Income | ||||||
| Net Interest Income | -23↓12.3% | -20↓39.3% | -14↑27.5% | -20↑5.9% | -21 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 23↑12.3% | 20↑39.3% | 14↓27.5% | 20↓5.9% | 21 | |
| Non-Operating Income | 99↑206.7% | -92↓143.8% | -38↓245.5% | -11↓260.5% | 7 | |
| Other Income / Expenses | -121↓267.5% | 72↑208.0% | 23↑363.5% | -9↑68.1% | -28 | |
| Income Before Tax | 442↑350.4% | -177↑67.5% | -543↑16.9% | -654↑61.9% | -1,715 | |
| Income Tax Expense | 2↓82.9% | 11↑435.9% | 2↓52.7% | 4↓85.3% | 29 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 440↑334.8% | -187↑65.6% | -545↑17.2% | -658↑62.3% | -1,744 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 440↑334.8% | -187↑65.6% | -545↑17.2% | -658↑62.3% | -1,744 | |
| Bottom-Line Net Income | 440↑334.8% | -187↑65.6% | -545↑17.2% | -658↑62.3% | -1,744 | |
| EPS (Basic) | 2.72↑321.1% | -1.23↑77.3% | -5.41↑35.7% | -8.42↑64.1% | -23.44 | |
| EPS (Diluted) | 2.54↑306.5% | -1.23↑77.3% | -5.41↑35.7% | -8.42↑64.1% | -23.44 | |
| Weighted Average Shares | 162↑6.4% | 152↑51.0% | 101↑28.9% | 78↑5.1% | 74 | |
| Weighted Average Diluted Shares | 173↑13.7% | 152↑51.0% | 101↑28.9% | 78↑5.1% | 74 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.